Filing Details

Accession Number:
0000899243-22-038601
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-15 16:30:21
Reporting Period:
2022-12-13
Accepted Time:
2022-12-15 16:30:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1756262 Transmedics Group Inc. TMDX Electromedical & Electrotherapeutic Apparatus (3845) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1773663 Miriam Provost C/O Transmedics Group, Inc.
200 Minuteman Road
Andover MA 01810
Vp, Global Regulatory Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-13 5,918 $38.46 19,469 No 4 M Direct
Common Stock Disposition 2022-12-13 2,695 $62.24 16,774 No 4 S Direct
Common Stock Disposition 2022-12-13 1,620 $63.00 15,154 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-12-13 5,918 $0.00 5,918 $38.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,105 2031-02-24 No 4 M Direct
Footnotes
  1. The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.70 to $62.69, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $62.72 to $63.32, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.